This podcast addresses the complexities of diagnosing and treating Hemophagocytic Lymphohistiocytosis (HLH), particularly in critically ill patients. It highlights the challenges in differentiating HLH from conditions like severe sepsis, emphasizing that delayed diagnosis is a major barrier to effective treatment. The discussion covers the limitations of relying solely on the presence of hemophagocytes in biopsy specimens or elevated ferritin levels for diagnosis, especially in adults where high ferritin can be associated with other conditions like renal disease. The H-score is presented as a valuable tool for early risk stratification. The podcast advocates for aggressive initiation of chemoimmunotherapy, such as etoposide, while acknowledging the concerns surrounding its use in patients with pancytopenia and organ failure.
Sign in to continue reading, translating and more.
Continue